Abstract
Novel HIV PR inhibitors, which contain a diaminopyranoside moiety as an inhibitor core unit, were designed based on the 3D structures of complexes of HIV-1 PR with transition-state mimics. These compounds were examined for their ability to inhibit the hydrolytic activity of a recombinant HIV-1 PR.
MeSH terms
-
Amino Acids, Diamino / chemical synthesis*
-
Amino Acids, Diamino / chemistry*
-
Amino Acids, Diamino / pharmacokinetics*
-
Drug Design*
-
HIV Protease Inhibitors / chemical synthesis*
-
HIV Protease Inhibitors / chemistry*
-
HIV Protease Inhibitors / pharmacokinetics*
-
Models, Chemical
Substances
-
Amino Acids, Diamino
-
HIV Protease Inhibitors